Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1993-1-21
|
pubmed:abstractText |
We studied the effects on vertebral bone density and lipid metabolism of long-term administration of 17 beta-oestradiol combined with norethisterone acetate in a 2-year prospective study carried out in 40 women, divided into 2 groups of 20 subjects. One group received treatment, while the other constituted the control group. In the untreated group, vertebral bone density was found to be decreased significantly by 1.1% at 12 months and by 4.4% at 24 months in relation to initial values (P < 0.001). Total cholesterol was significantly higher (P < 0.05) at the end of the 2-year period. By contrast, in the treated group, bone density showed significant increases of 5.6% at 12 months and 7% at 24 months (P < 0.001). Significant reductions in the biochemical markers of bone remodelling (osteocalcin and the urinary calcium/urinary creatinine ratio) were also observed. Total cholesterol, high-density-lipoprotein cholesterol, low-density-lipoprotein cholesterol and triglycerides did not change significantly during treatment. These results, as well as the good compliance with treatment (78%), suggest that this treatment regimen could be useful in the prevention of postmenopausal bone loss.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Estradiol,
http://linkedlifedata.com/resource/pubmed/chemical/Lipids,
http://linkedlifedata.com/resource/pubmed/chemical/Norethindrone,
http://linkedlifedata.com/resource/pubmed/chemical/Osteocalcin,
http://linkedlifedata.com/resource/pubmed/chemical/Progesterone Congeners,
http://linkedlifedata.com/resource/pubmed/chemical/norethindrone acetate
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0378-5122
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
217-23
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:1465035-Bone Density,
pubmed-meshheading:1465035-Estradiol,
pubmed-meshheading:1465035-Female,
pubmed-meshheading:1465035-Humans,
pubmed-meshheading:1465035-Lipids,
pubmed-meshheading:1465035-Lumbar Vertebrae,
pubmed-meshheading:1465035-Menopause,
pubmed-meshheading:1465035-Middle Aged,
pubmed-meshheading:1465035-Norethindrone,
pubmed-meshheading:1465035-Osteocalcin,
pubmed-meshheading:1465035-Progesterone Congeners,
pubmed-meshheading:1465035-Prospective Studies
|
pubmed:year |
1992
|
pubmed:articleTitle |
Effect of 17 beta-oestradiol and norethisterone acetate on vertebral bone mass and lipid metabolism in early postmenopausal women.
|
pubmed:affiliation |
Service d'Endocrinologie, U.F. Maladies Osseuses et Metaboliques, C.H.U. Purpan, Toulouse, France.
|
pubmed:publicationType |
Journal Article
|